Not registered yet? Get a free account.
Sign UpYou're about to leave our website and go to an external link. Are you sure?
Gland Pharma Ltd, is a listed public company incorporated on 20 March, 1978. It is classified as a public limited company and is located in Medchal Malkajgiri District Hy, Telangana. It's authorized share capital is INR 56.30 cr and the total paid-up capital is INR 16.50 cr.
Gland Pharma Ltd's operating revenue range is Over INR 500 cr for the financial year ending on 31 March, 2025. It's EBITDA has increased by 2.4% over the previous year. At the same time, it's book networth has increased by 8.45%.
Read more
** All rupee values in INR crores.
* GST not included
** Reports & MCA filings will be based on the latest available financials.
** Delivery timelines are on best-effort basis during working hours. Filings 3-4 hours. Reports 24-48 hours.
* INR 349 for 20+ credits purchase
1 credit = one company dashboard
| State | Type | Address |
|---|
| Designation | Name | DIN/PAN | Tenure |
|---|---|---|---|
| Director | Jia Ai Zhang | 09170927 | 5 years |
| Director | Naina Lal Kidwai | 00017806 | 5 years |
| Director | Essaji Goolam Vahanvati | 00157299 | 6 years |
| Whole-time director | Srinivas Sadu | 06900659 | 8 years |
| Director | Udo Jahannes Vetter | 00707474 | 5 years |
| Director | Wei Huang | 10818586 | 2 years |
| Additional Director | Xingli Wang | 11899926 | 0 years |
| Director | William Robert Keller | 11593622 | 0 years |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Networth | |||||
| Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Financials upto March 2025 available in Tofler Pro
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
As per information available, the company has no registered charges.
| Name | Status | Paid up Capital | Common Directors | Address |
|---|---|---|---|---|
| NAYARA ENERGY LIMITED |
Active
|
1,488.4 Cr | 1 | Gujarat |
| ROTHSCHILD & CO INDIA PRIVATE LIMITED |
Active
|
13.5 Cr | 1 | Maharashtra |
| UPL LIMITED |
Active
|
168.9 Cr | 1 | Gujarat |
| BIOCON LIMITED |
Active
|
814.8 Cr | 1 | Karnataka |
| JBM SOFTWARE DEVELOPMENT PRIVATE LIMITED |
Strike Off
|
1.0 L | 1 | Maharashtra |
| LENIENT FINVEST PRIVATE LIMITED |
Amalgamated
|
4.8 Cr | 1 | Maharashtra |
| SAFARI MERCANTILE PRIVATE LIMITED |
Amalgamated
|
4.8 Cr | 1 | Maharashtra |
| LUXURY LINK INDIA PRIVATE LIMITED |
Amalgamated
|
10.0 L | 1 | Maharashtra |
| AUGUSTA CONSULTANTS AND ADVISORS PRIVATE LIMITED |
Active
|
1.0 Cr | 1 | Maharashtra |
| DR. GOOLAM E VAHANVATI FOUNDATION |
Active
|
1.0 L | 1 | Maharashtra |
| MOORI EATERY PRIVATE LIMITED |
Active
|
1.0 L | 1 | Maharashtra |
| AGB OILS LLP |
Active
|
4.0 L | 1 | Maharashtra |
| BAGH TOLA JUNGLE LODGES LLP |
Active
|
25,000.0 | 1 | Maharashtra |
| R & V LEGAL ADVISORS LLP |
Active
|
50,000.0 | 1 | Maharashtra |
| ELCID INVESTMENTS LIMITED |
Active
|
20.0 L | 1 | Maharashtra |
| BENNETT COLEMAN AND COMPANY LIMITED |
Active
|
287.0 Cr | 1 | Maharashtra |
| PASCHAL TECHNOLOGY (INDIA) PRIVATE LIMIT ED |
Amalgamated
|
2.1 Cr | 1 | Telangana |
| PASCHAL FORM WORK (INDIA) PRIVATE LIMITED |
Active
|
36.2 Cr | 1 | Andhra Pradesh |
| SADU ADVISORY SERVICES PRIVATE LIMITED |
Active
|
1.0 L | 1 | Telangana |
| Name | State / Country | Incorporation Year | Paidup Capital |
|---|---|---|---|
| Gland Pharma International Pte Ltd | Singapore | - | - |
| GLAND PHARMA USA INC | United States | - | - |
| Manxen SAS | France | - | - |
| Manxen 2 SAS | France | - | - |
| Manxen 3 SAS | France | - | - |
| Phixen SAS | France | - | - |
| Cenexi SAS | France | - | - |
| Cenexi Laboratories Thissen SA | Belgium | - | - |
| Cenexi HSC SAS | France | - | - |
| Cenexi 2 SASU | France | - | - |
| Phineximmo SA | Belgium | - | - |
| Cenexi Services SAS | France | - | - |
| Cenexi 3 SASU | France | - | - |
| Gland Pharma International Pte. Ltd. | Singapore | - | - |
| Gland Pharma USA Inc. | United States | - | - |
Read more
The incorporation date of GLAND PHARMA LTD is 20 March, 1978
The authorized share capital of GLAND PHARMA LTD is INR ₹ 56.3 Cr.
The paid-up capital of GLAND PHARMA LTD is INR ₹ 16.5 Cr.
The registered address of GLAND PHARMA LTD is SY.NO.143-148,150 &151,NEAR GANDI MAISAMMA X ROADS D.P.PALLY,DUNDIGAL, DUNDIGAL - GANDIMAIS AMMA(M) MEDCHAL MALKAJGIRI DISTRICT HY Telangana - 500043
The CIN number of GLAND PHARMA LTD is L24239TG1978PLC002276.